Latest News
What works for brain health supplements and how to choose
The brain is a demanding organ, using up a surprising amount of the body’s resources every day. It’s no wonder that more people are looking into ways to support memory, focus, and mental energy as the years go by—often turning to products designed for cognitive support. With so many options out there, it can be [...]
Via Visibility · December 26, 2025
Explore how cost and portfolio breadth set these two small-cap value ETFs apart for investors seeking tailored exposure.
Via The Motley Fool · December 27, 2025
Nebius Group and Applied Digital have had an amazing 2025.
Via The Motley Fool · December 27, 2025
Why a $34 Million Teva Stock Position Signals Confidence in a Long Repair Story
Via The Motley Fool · December 27, 2025
Figma and CoreWeave could head higher as the AI market expands.
Via The Motley Fool · December 27, 2025
Investors will get to review the company's latest financial results early in January.
Via The Motley Fool · December 27, 2025
If you're investing for the long run, there are a myriad of companies begging to be bought.
Via The Motley Fool · December 27, 2025
Netflix's Warner Bros. deal puts capital discipline -- and valuation -- under a harsher spotlight.
Via The Motley Fool · December 27, 2025
These businesses are innovators in their respective industries.
Via The Motley Fool · December 27, 2025
These could be compelling businesses worth buying and holding for the long run.
Via The Motley Fool · December 27, 2025
A new study finds that Facebook hosts the vast majority of social media scams, and critics argue it is because Meta prioritizes profit over protecting users. Internal documents show Meta projected $16 billion from scam ads last year.
Via Talk Markets · December 27, 2025
The company is making a major shift in its business.
Via The Motley Fool · December 27, 2025
My focus is on where capital rotated this quarter, at the sector level. With only three trading days remaining in 2025, the Q4 data is essentially complete—giving us a meaningful foundation to assess how Q1 2026 may unfold.
Via Talk Markets · December 27, 2025
Teladoc's collapse has been dramatic. But are shares cheap enough to make them a buy?
Via The Motley Fool · December 27, 2025
Rocket Lab closed Friday at $70.65, down 8.46% from Thursday’s levels, after swinging between $70.39 and $76.99 on unusually low holiday trading volume of 23.16 million shares. Investors attributed the drop to profit-taking and thin market liquidity.
Via Talk Markets · December 27, 2025
The new "Magnificent Seven" is better suited for today's current market.
Via The Motley Fool · December 27, 2025
This video dives into cycle analysis on silver, and discusses why the silver bear markets between bull runs have been shortening significantly.
Via Talk Markets · December 27, 2025
Rivian stock performed very well in 2025. Next year could bring more gains.
Via The Motley Fool · December 27, 2025
I believe tokenization is inevitable. And earlier this month, one of the largest and most conservative financial institutions in the world took a step that makes the shift to tokenization impossible to ignore.
Via Talk Markets · December 27, 2025
Nvidia stock is on sale right now.
Via The Motley Fool · December 27, 2025
Known for workplace safety and identification solutions, this industrial supplier reported a notable insider sale in its latest SEC filing.
Via The Motley Fool · December 27, 2025
Via Benzinga · December 27, 2025
Groq recently announced that it entered into a non-exclusive licensing agreement with Nvidia for Groq's inference technology. Here is a quick look at what analysts had to say about the deal.
Via Talk Markets · December 27, 2025
A Santa Claus rally appears underway, but what does that portend for 2026?
Via The Motley Fool · December 27, 2025
Expense ratios, dividend yields, and sector mix set these two Vanguard ETFs apart for investors seeking the right market balance.
Via The Motley Fool · December 27, 2025
